A board investigation does not automatically require a CEO to resign or take leave. The board should select interim measures that protect evidence, decision-making, security, and stakeholder confidence without treating unresolved allegations as proven.
That question became immediate after Nvidia announced an independent investigation into reporting that CEO Jensen Huang had been targeted by a foreign intelligence effort. The board's announcement did not state that misconduct or a security compromise had been established.
The governance challenge is broader than one company. When the subject of an investigation is also a founder, chief executive, major shareholder, or central public figure, directors must decide whether ordinary reporting lines can support a credible review.
Start With the Risk the Interim Measure Must Control
Administrative leave is a tool, not a conclusion. Before choosing it, the board should identify the specific risk it is trying to manage.
Relevant risks may include:
• The ability to alter, delete, or influence evidence.
• Access to confidential, privileged, classified, or export-controlled information.
• Influence over witnesses, investigators, directors, or employees.
• Continued participation in decisions affected by an alleged conflict.
• Market, customer, government, or employee confidence.
• Disruption to operations, financing, strategy, or succession.
• Retaliation against reporters or witnesses.
A measure should be connected to an identified risk. Removing an executive from every function may be unnecessary when a targeted recusal or access restriction can protect the process. A narrow measure may be insufficient when the executive can influence evidence or the investigators' reporting line.
Confirm Who Has Authority to Act
The board should review the charter, bylaws, committee mandates, employment agreement, equity plans, succession arrangements, and applicable law before changing the CEO's duties or status.
Under Section 141 of the Delaware General Corporation Law, the business and affairs of a Delaware corporation generally are managed by or under the direction of its board. The statute also permits boards to establish committees with delegated authority, subject to statutory and organizational limits.
Authority does not answer every fiduciary question. The record should show which directors participated, how conflicts were evaluated, what advice was received, and why the chosen measure was proportionate.
Test the Independence of the Decision-Makers
An investigation is not independent merely because its announcement uses that word. Independence depends on relationships, incentives, authority, access, and the ability to make decisions without control by the subject.
The board should consider whether participating directors have personal, financial, professional, or other ties that could reasonably call their judgment into question. It also should examine whether management controls the investigators' budget, documents, personnel access, or communications.
Delaware courts scrutinize the independence and process of special committees in context. In one Court of Chancery decision discussing a special litigation committee, the court emphasized that a conflicted board may seek to restore decision-making through an empowered independent committee, while the committee's independence and investigation remain central to the analysis.
The purpose is not to create the appearance of independence. It is to create a process capable of reaching and implementing a decision even if the conclusion is unfavorable to a powerful executive.
The Board Has a Spectrum, Not a Binary Choice
Boards often have more choices than immediate termination or no action. The correct position on that spectrum depends on how much authority must change to protect the investigation.
Targeted recusal and access restrictions
The CEO may remain in office while being recused from a customer relationship, government matter, transaction, or security decision. The board can also limit access to specified systems, facilities, information, or personnel. These measures work only if they are technically enforceable and independently monitored.
Delegation and temporary role changes
Defined responsibilities may move to a lead independent director, another officer, or an acting executive. Security, legal, compliance, or internal audit personnel may receive a different reporting line so investigators and witnesses are not dependent on the subject of the review.
Administrative leave or removal
Leave may be appropriate when narrower controls cannot protect evidence, witnesses, security, or decision-making. Removal is a separate decision that may require stronger factual findings, contractual analysis, succession planning, and disclosure review.
Whatever measure is selected should have a documented scope, start date, responsible owner, review date, and conditions for modification or termination.
Protect the Investigation Without Declaring Guilt
Interim controls should be framed as protective measures, not factual findings. Internal and public communications should avoid language suggesting that the board has already decided the disputed issue.
At the same time, boards should not use neutral wording to conceal meaningful action. Employees, regulators, and investors may need accurate information about who is exercising authority and whether leadership duties have changed.
The Nvidia board statement confirms the independent investigation. Reporting by the Associated Press describes what is known and what remains unresolved. These sources should not be read as a final finding regarding the underlying intelligence allegations.
Preserve Leadership Continuity
A founder-led company may depend heavily on one executive for product direction, financing relationships, government engagement, customer confidence, and public communication. That dependence is itself a governance fact.
The board should identify which duties must continue and who can perform them if the CEO's role changes temporarily. Succession planning may address:
• Signing and delegated authority.
• Earnings calls and investor communications.
• Government and national-security contacts.
• Strategic customer and supplier decisions.
• Personnel and compensation authority.
• Security and export-control approvals.
• Crisis communications.
Continuity planning should not become a reason to weaken the investigation. It should reduce the operational cost of taking necessary protective action.
Reassess the Measure as Evidence Develops
An interim measure should not continue by inertia. The board or committee should establish review points and ask whether the original risk remains, has increased, or can be managed differently.
New evidence may support broader restrictions, restoration of duties, remediation, disciplinary action, disclosure, referral to authorities, or closure without adverse findings.
The decision file should distinguish the evidence available at each stage. A decision that was reasonable on day one may need to change after a forensic review, witness interview, government request, or verified security event.
Keep the Governance Record Coherent
The board should preserve its mandate, conflict analysis, committee resolutions, advice received, evidence considered, interim measures, review dates, and final decision. Minutes should demonstrate oversight without unnecessarily reproducing privileged legal advice.
Alloomi AI can support authorized legal teams by organizing investigation records, chronologies, policies, and source-linked issue lists for lawyer review. It should not determine whether a director is independent or whether an executive must step aside.
The broader principle is traceability: the company should be able to explain who made the decision, which evidence informed it, and what changed over time.
Conclusion
There is no automatic rule that a CEO must step aside whenever a board begins an investigation. Directors should focus on the risks to evidence, security, independence, decision-making, continuity, and stakeholder trust.
A defensible response considers a range of interim controls, assigns authority to independent decision-makers, protects the presumption that allegations remain unresolved, and revisits the measure as facts develop.
Three Questions Directors Usually Ask
1. Does administrative leave mean the board believes the allegation?
No. Properly framed leave can protect an investigation and the company without expressing a final conclusion.
2. Can a CEO remain in office but be recused from certain matters?
Yes. A targeted recusal may be appropriate when the risk is limited and the board can enforce the restriction effectively.
3. Should the company announce every interim restriction?
Not necessarily. Disclosure depends on the measure, applicable reporting rules, materiality, existing statements, and the need to communicate who is exercising authority.
